OREANDA-NEWS. uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that its management will be presenting at the below listed investor conferences in May and June, 2016.

  • Piper Jaffray GenomeRx Symposium

Venue: The InterContinental New York Barclay Hotel, New York City
Title: Getting to the Heart (& Muscle) of the Gene Therapy Matter
Presenter: Christian Meyer, Chief Medical Officer 
Date and Time: May 17, 2016: 10.40 AM EDT

  • 2016 UBS Global Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City 
Presenter: Daniel Soland, Chief Executive Officer 
Date and Time: May 24, 2016: 08.00 AM EDT 
Webcast: A webcast of the presentation will be available through the details listed below

  • Jefferies 2016 Healthcare Conference

Venue: Grand Hyatt New York Hotel, New York City 
Presenter: Matt Kapusta, Chief Financial Officer 
Date and Time: June 10, 2016: 11.00 AM EDT

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. Leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases.